Clover Health Investments Q4 Earnings Call Highlights

Core Insights - Clover Health achieved full-year Adjusted EBITDA profitability in 2025, with a well-controlled medical cost trend and significant membership growth despite industry challenges [2][3][5] Membership Growth - Medicare Advantage membership grew by 38% year-over-year to approximately 114,000 members at year-end, with a 53% growth during the 2026 annual enrollment period [5][6][7] - The growth was driven by Clover's risk-bearing model, strong retention, and expanded use of the Clover Assistant platform [5][6] Financial Performance - Insurance revenue for Q4 2025 was $486 million, up 47% year-over-year, while full-year insurance revenue reached $1.9 billion, a 41% increase [7] - Total revenue for 2025 increased by 40% year-over-year [7] - Consolidated Gross Profit for 2025 was $356 million, with guidance for 2026 set between $470 million and $510 million [4][8] Cost Management - Underlying medical cost trends (excluding pharmacy) were well controlled at approximately 5% year-over-year [4][7] - Adjusted SG&A in Q4 was $98 million, slightly above expectations, but as a percentage of total revenue, it improved by 560 basis points year-over-year [10] Future Outlook - Clover expects 2026 to be its first full year of GAAP net income profitability, with net income guidance breakeven to $20 million [5][14][16] - Revenue guidance for 2026 is set between $2.81 billion and $2.92 billion, indicating a 49% year-over-year growth at the midpoint [16] Strategic Initiatives - The company is focusing on improving long-term economics and clinical integration through its Clover Assistant platform [13][20] - Management emphasized the importance of maintaining balance sheet strength and liquidity while selectively reinvesting in quality improvement and care management [13]